Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company formed to pursue a business combination in the biotechnology and life sciences sector. The company filed a Form 10-Q with the SEC on August 22, 2022, accession number 0001213900-22-050049, reflecting its status as an active special purpose acquisition company at that time. BIOT was positioned to target opportunities across therapeutics, diagnostics, and adjacent life sciences verticals, a segment that attracted significant SPAC formation activity during the 2021 and 2022 vintage years. Sponsor details and full deal history are available in the SpacDesk database — sign up at SpacDesk to access complete filings, sponsor profiles, and SPAC analytics.